Detalles de la búsqueda
1.
Effect of Bimekizumab on Patient-Reported Disease Impact in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies.
Rheumatology (Oxford)
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38754125
2.
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
Rheumatology (Oxford)
; 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38218744
3.
Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis.
Rheumatology (Oxford)
; 2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37947318
4.
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France - a cohort study using the French National Healthcare database (SNDS).
Ann Hematol
; 100(7): 1825-1836, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33884454
5.
Fidaxomicin compared with vancomycin and metronidazole for the treatment of Clostridioides (Clostridium) difficile infection: A network meta-analysis.
J Infect Chemother
; 26(1): 43-50, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31624029
6.
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.
Arthritis Res Ther
; 26(1): 50, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360699
7.
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.
J Med Econ
; 27(1): 682-696, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38650583
8.
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Rheumatol Ther
; 11(3): 829-839, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38488975
9.
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
Rheumatol Ther
; 11(3): 817-828, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38446397
10.
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2.
RMD Open
; 10(2)2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599650
11.
Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
RMD Open
; 10(1)2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38296802
12.
Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies.
RMD Open
; 10(2)2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38834351
13.
Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis.
RMD Open
; 9(4)2023 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035757
14.
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthritis.
Ther Adv Musculoskelet Dis
; 15: 1759720X231189079, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37663034
15.
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopa.
J Mark Access Health Policy
; 10(1): 2010961, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35035792
16.
Achievement of more stringent disease control is associated with reduced burden on workplace and household productivity: results from long-term certolizumab pegol treatment in patients with psoriatic arthritis.
Ther Adv Musculoskelet Dis
; 14: 1759720X221140846, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533099
17.
Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis.
Dermatol Ther (Heidelb)
; 12(8): 1777-1792, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35798920
18.
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study.
ACR Open Rheumatol
; 4(9): 819-824, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833532
19.
Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients - a Bayesian network meta-analysis.
Curr Med Res Opin
; 37(2): 225-244, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079575
20.
Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials.
Cardiovasc Ther
; 2020: 3057168, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32695228